IP Library Granted Patent US 10,934,295
Granted Patent B2
US 10,934,295 · App. 16/099,136 · Granted Mar 2, 2021

Antimicrobials and methods of making and using same

Inventors: Erin M. Duffy (Deep River, CT); Ashoke Bhattacharjee (Cheshire, CT); Zoltan F. Kanyo (North Haven, CT); Joseph A. Ippolito (Guilford, CT)
Assignee: BIOVERSYS AG
C07D487/04A61P31/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,934,295
App. No.
16/099,136
Granted
Mar 2, 2021
Kind
B2
Abstract

The present disclosure relates generally to the field of antimicrobial compounds and to methods of making and using them. These compounds are useful for treating, preventing, reducing the risk of, and delaying the onset of microbial infections in humans and animals. In some embodiments, the present disclosure provides a compound of Formula (I): or a tautomer thereof or a pharmaceutically acceptable salt of the compound or tautomer.

Claims (36)

1. A compound of Formula (I)

or a tautomer or a pharmaceutically acceptable salt of the compound or tautomer, wherein:

R 1 is halo;

R 2 is halo;

R 3 is selected from, C 1-6 alkyl, NR c1 R d1 , NO 2 , OR a1 , SR a1 , S(O) 2 R b1 , and 5- to 6-membered heterocycloalkyl, wherein the C 1-6 alkyl is optionally substituted with a substituent selected from C(O)OR a1 , C(O)NR c1 R d1 , and C 1-4 alkoxy, and wherein the C 1-4 alkoxy is optionally substituted with C 1-4 alkoxy;

R 4 is selected from H, C 1-6 alkyl, and C 2-6 alkenyl, wherein the C 1-6 alkyl is optionally substituted with a substituent selected from OR a2 , SR a2 , NR c2 R d2 , and NR c2 C(=NR c2 )NR c2 R d2 ,

X is selected from 0, NR S , and CH 2 ;

R 5 is selected from H and C 1-4 alkyl;

W is selected from CR 6A R 6B and NR 6A ;

Y is N or CR 3 ;

R 6A is selected from H, C 1-6 alkyl, and C 1-6 haloalkyl;

R 6B is H; or

R 6A and R 6B together form an oxo group; or

R 6A and R 4 together with the carbon atom to which R 4 is attached, the W atom to which R 6A is attached and the X atom connecting W and the carbon atom to which R 4 is attached, form a 5- to 6-membered heterocycloalkyl ring containing 1-3 heteroatoms;

R 7 is selected from C 1-4 alkyl, C 1-4 haloalkyl, and C 3-5 cycloalkyl;

each of Ra a1 , R b1 , R c1 , R d1 , R a2 , R c2 , and R d2 is independently selected from H, C 1-4 alkyl, C 1-4 haloalkyl, and 5- to 6-membered heteroaryl; and

R 8 is selected from H, C 1-4 alkenyl, C 1-4 haloalkyl and C 1-4 alkyl optionally substituted with a substituent selected from amino, C 1-4 alkoxy, C 3-5 cycloalkyl, and 3- to 6-membered heterocycloalkyl;

R 9 is selected from H and halo; and

R e2 is selected from H and C 1-4 alkyl.

2. The compound of claim 1 , wherein R 1 is fluoro.

3. The compound of any one of claims 1 and 2 , wherein R 2 is chloro.

4. The compound of any one of claims 1 and 2 , wherein Y is CR 3 and R 3 is selected from, NO 2 , methylsulfonyl, methoxy, methylthio, carboxymethyl, methylaminocarbonylmethyl, N-morpholino, (2-methoxyethoxy)methyl, and dimethyl amino.

5. The compound of any one of claims 1 and 2 , wherein R 4 is selected from H, methyl, methylthiomethyl, hydroxymethyl, CH 2 NH(imidazol-2-yl), guanidinomethyl, ethenyl, CH 2 NH(pyridin-2-yl), and aminomethyl.

6. The compound of any one of claims 1 and 2 , wherein R 4 is H.

7. The compound of any one of claims 1 and 2 , wherein X is NR 5 .

8. The compound of any one of claims 1 and 2 , wherein X is O.

9. The compound of any one of claims 1 and 2 , wherein X is CH 2 .

10. The compound of any one of claims 1 and 2 , wherein W is CR 6A R 6B .

11. The compound of any one of claims 1 and 2 , wherein W is NR 6A .

12. The compound of any one of claims 1 and 2 , wherein R 6A is selected from H, methyl, trifluoromethyl, and difluoromethyl.

13. The compound of any one of claims 1 and 2 , wherein R 6A and R 6B together form an oxo group.

14. The compound of any one of claims 1 and 2 , wherein R 6A and R 4 together with the carbon atom to which R 4 is attached, the W atom to which R 6A is attached and the X atom connecting W and the carbon atom to which R 4 is attached, form a ring of any one of the following formulae:

15. The compound of any one of claims 1 and 2 , wherein R 6A and R 4 together with the carbon atom to which R 4 is attached, the W atom to which R 6A is attached and the X atom connecting W and the carbon atom to which R 4 is attached, form a ring of formula:

wherein x indicates a point of attachment to the ring containing Y.

16. The compound of any one of claims 1 and 2 , wherein R 7 is selected from methyl, trifluoromethyl, and cyclopropyl.

17. The compound of claim 1 , wherein R 9 is H.

Assignments (15)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2020
From: MELINTA THERAPEUTICS, INC.; MELINTA SUBSIDIARY CORP.
To: BIO VERSYS AG
Reel/Frame 052438/0721 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2020
From: BHATTACHARJEE, ASHOKE
To: RIB-X PHARMACEUTICALS, INC.
Reel/Frame 052438/0544 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2020
From: DUFFY, ERIN M.
To: RIB-X PHARMACEUTICALS, INC.
Reel/Frame 052438/0555 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2020
From: MARRA, ANDREA
To: RIB-X PHARMACEUTICALS, INC.
Reel/Frame 052438/0590 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2020
From: IPPOLITO, JOSEPH A.
To: RIB-X PHARMACEUTICALS, INC.
Reel/Frame 052438/0629 →
CHANGE OF NAME Recorded Apr 20, 2020
From: RIB-X PHARMACEUTICALS, INC.
To: MELINTA THERAPEUTICS, INC.
Reel/Frame 052438/0829 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 20, 2020
From: KANYO, ZOLTAN
To: RIB-X PHARMACEUTICALS, INC.
Reel/Frame 052438/0535 →
CHANGE OF NAME Recorded Oct 22, 2019
From: RIB-X PHARMACEUTICALS, INC.
To: MELINTA THERAPEUTICS, INC.
Reel/Frame 050785/0964 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 22, 2019
From: DUFFY, ERIN M
To: RIB-X PHARMACEUTICALS, INC.
Reel/Frame 050790/0489 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 22, 2019
From: IPPOLITO, JOSEPH
To: RIB-X PHARMACEUTICALS, INC.
Reel/Frame 050790/0720 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 22, 2019
From: BHATTACHARJEE, ASHOKE
To: RIB-X PHARMACEUTICALS, INC.
Reel/Frame 050791/0440 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 22, 2019
From: KANYO, ZOLTAN
To: RIB-X PHARMACEUTICALS, INC.
Reel/Frame 050791/0648 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 22, 2019
From: MELINTA THERAPEUTICS, INC.; MELINTA SUBSIDIARY CORP.
To: BIOVERSYS AG
Reel/Frame 050128/0253 →
RELEASE OF SECURITY INTEREST Recorded Apr 11, 2019
From: CORTLAND CAPITAL MARKET SERVICES LLC, AS AGENT
To: MELINTA THERAPEUTICS, INC.
Reel/Frame 048875/0750 →
SECURITY INTEREST Recorded Mar 19, 2019
From: MELINTA THERAPEUTICS, INC.; REMPEX PHARMACEUTICALS, INC.; CEMPRA PHARMACEUTICALS, INC.; MELINTA SUBSIDIARY CORP.
To: CORTLAND CAPITAL MARKET SERVICES LLC, AS AGENT
Reel/Frame 048637/0784 →